Launch of the UK SABR Consortium Pelvic Stereotactic Ablative Radiotherapy Re-irradiation Guidelines and National Audit

Affiliations

¹ UK SABR Consortium Committee, UK; Department of Clinical Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Clinical Oncology Quality Improvement and Audit Committee, Royal College of Radiologists, London, UK. Electronic address: rebeccamuirhead@oncology.ox.ac.uk.
² UK SABR Consortium Committee, UK; Radiotherapy Physics, Barts Health NHS Trust, London, UK.
³ UK SABR Consortium Committee, UK; National Radiotherapy Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK.
⁴ Clinical Oncology Quality Improvement and Audit Committee, Royal College of Radiologists, London, UK; Department of Clinical Oncology, Imperial College Healthcare NHS Trust, London, UK.
⁵ Lung Unit, Royal Marsden NHS Foundation Trust, London, UK; UK SABR Consortium Committee, UK.

Editorial

R Muirhead et al. Clin Oncol (R Coll Radiol). 2023 Jan.

. 2023 Jan;35(1):29-32.

doi: 10.1016/j.clon.2022.09.047. Epub 2022 Oct 6.

¹ UK SABR Consortium Committee, UK; Department of Clinical Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Clinical Oncology Quality Improvement and Audit Committee, Royal College of Radiologists, London, UK. Electronic address: rebeccamuirhead@oncology.ox.ac.uk.
² UK SABR Consortium Committee, UK; Radiotherapy Physics, Barts Health NHS Trust, London, UK.
³ UK SABR Consortium Committee, UK; National Radiotherapy Quality Assurance Group, Mount Vernon Cancer Centre, Northwood, UK.
⁴ Clinical Oncology Quality Improvement and Audit Committee, Royal College of Radiologists, London, UK; Department of Clinical Oncology, Imperial College Healthcare NHS Trust, London, UK.
⁵ Lung Unit, Royal Marsden NHS Foundation Trust, London, UK; UK SABR Consortium Committee, UK.

No abstract available

Publication types